Financhill
Buy
76

GRDN Quote, Financials, Valuation and Earnings

Last price:
$33.03
Seasonality move :
11.77%
Day range:
$32.37 - $33.93
52-week range:
$17.78 - $37.43
Dividend yield:
0%
P/E ratio:
52.69x
P/S ratio:
1.53x
P/B ratio:
11.56x
Volume:
147.8K
Avg. volume:
236.6K
1-year change:
66.78%
Market cap:
$2.1B
Revenue:
$1.2B
EPS (TTM):
$0.64

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
GRDN
Guardian Pharmacy Services, Inc.
$390M $0.27 1.74% 64.78% $35.00
BKD
Brookdale Senior Living, Inc.
$770.5M -$0.18 -4.15% -82.25% $19.38
ENSG
The Ensign Group, Inc.
$1.4B $1.77 19.01% 32.44% $220.40
LFST
Lifestance Health Group, Inc.
$378.5M $0.05 14.18% -95.93% $8.89
PACS
PACS Group, Inc.
$1.4B $0.46 8.08% 132.17% $44.20
PNTG
The Pennant Group, Inc.
$275.2M $0.32 33.38% 36.71% $37.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
GRDN
Guardian Pharmacy Services, Inc.
$33.54 $35.00 $2.1B 52.69x $0.00 0% 1.53x
BKD
Brookdale Senior Living, Inc.
$14.90 $19.38 $3.5B -- $0.00 0% 1.10x
ENSG
The Ensign Group, Inc.
$210.64 $220.40 $12.2B 36.04x $0.07 0.12% 2.45x
LFST
Lifestance Health Group, Inc.
$7.15 $8.89 $2.8B -- $0.00 0% 2.02x
PACS
PACS Group, Inc.
$38.68 $44.20 $6B 37.30x $0.00 0% 1.23x
PNTG
The Pennant Group, Inc.
$32.32 $37.50 $1.1B 42.72x $0.00 0% 1.35x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
GRDN
Guardian Pharmacy Services, Inc.
15.65% -0.985 2.04% 0.88x
BKD
Brookdale Senior Living, Inc.
100.82% -0.785 214.97% 0.55x
ENSG
The Ensign Group, Inc.
49.71% 1.150 21.83% 1.36x
LFST
Lifestance Health Group, Inc.
24.09% -0.344 22.14% 1.42x
PACS
PACS Group, Inc.
80.75% 0.835 171.05% 0.82x
PNTG
The Pennant Group, Inc.
48.47% 0.110 33.81% 0.90x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
GRDN
Guardian Pharmacy Services, Inc.
$74.7M $16.8M 19.18% 24.04% 4.46% $23M
BKD
Brookdale Senior Living, Inc.
$68M $27.3M -4.65% -312.72% 3.62% -$29.1M
ENSG
The Ensign Group, Inc.
$194.6M $123.7M 8.38% 16.96% 9.09% $133.5M
LFST
Lifestance Health Group, Inc.
$103M $8M -0.47% -0.62% 2.19% $17M
PACS
PACS Group, Inc.
$188.8M $86.4M 3.89% 21.93% 6.42% $186.8M
PNTG
The Pennant Group, Inc.
$29.5M $13.3M 4.83% 9.98% 5.8% $10.5M

Guardian Pharmacy Services, Inc. vs. Competitors

  • Which has Higher Returns GRDN or BKD?

    Brookdale Senior Living, Inc. has a net margin of 2.54% compared to Guardian Pharmacy Services, Inc.'s net margin of -5.3%. Guardian Pharmacy Services, Inc.'s return on equity of 24.04% beat Brookdale Senior Living, Inc.'s return on equity of -312.72%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services, Inc.
    19.8% $0.15 $229.6M
    BKD
    Brookdale Senior Living, Inc.
    9.02% -$0.17 $5.5B
  • What do Analysts Say About GRDN or BKD?

    Guardian Pharmacy Services, Inc. has a consensus price target of $35.00, signalling upside risk potential of 4.35%. On the other hand Brookdale Senior Living, Inc. has an analysts' consensus of $19.38 which suggests that it could grow by 30.03%. Given that Brookdale Senior Living, Inc. has higher upside potential than Guardian Pharmacy Services, Inc., analysts believe Brookdale Senior Living, Inc. is more attractive than Guardian Pharmacy Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services, Inc.
    3 0 0
    BKD
    Brookdale Senior Living, Inc.
    2 0 0
  • Is GRDN or BKD More Risky?

    Guardian Pharmacy Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Brookdale Senior Living, Inc. has a beta of 0.696, suggesting its less volatile than the S&P 500 by 30.407%.

  • Which is a Better Dividend Stock GRDN or BKD?

    Guardian Pharmacy Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Brookdale Senior Living, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services, Inc. pays 128.01% of its earnings as a dividend. Brookdale Senior Living, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GRDN or BKD?

    Guardian Pharmacy Services, Inc. quarterly revenues are $377.4M, which are smaller than Brookdale Senior Living, Inc. quarterly revenues of $754.1M. Guardian Pharmacy Services, Inc.'s net income of $9.6M is higher than Brookdale Senior Living, Inc.'s net income of -$40M. Notably, Guardian Pharmacy Services, Inc.'s price-to-earnings ratio is 52.69x while Brookdale Senior Living, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services, Inc. is 1.53x versus 1.10x for Brookdale Senior Living, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services, Inc.
    1.53x 52.69x $377.4M $9.6M
    BKD
    Brookdale Senior Living, Inc.
    1.10x -- $754.1M -$40M
  • Which has Higher Returns GRDN or ENSG?

    The Ensign Group, Inc. has a net margin of 2.54% compared to Guardian Pharmacy Services, Inc.'s net margin of 7.02%. Guardian Pharmacy Services, Inc.'s return on equity of 24.04% beat The Ensign Group, Inc.'s return on equity of 16.96%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services, Inc.
    19.8% $0.15 $229.6M
    ENSG
    The Ensign Group, Inc.
    14.3% $1.61 $4.4B
  • What do Analysts Say About GRDN or ENSG?

    Guardian Pharmacy Services, Inc. has a consensus price target of $35.00, signalling upside risk potential of 4.35%. On the other hand The Ensign Group, Inc. has an analysts' consensus of $220.40 which suggests that it could grow by 4.63%. Given that The Ensign Group, Inc. has higher upside potential than Guardian Pharmacy Services, Inc., analysts believe The Ensign Group, Inc. is more attractive than Guardian Pharmacy Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services, Inc.
    3 0 0
    ENSG
    The Ensign Group, Inc.
    3 1 0
  • Is GRDN or ENSG More Risky?

    Guardian Pharmacy Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Ensign Group, Inc. has a beta of 0.876, suggesting its less volatile than the S&P 500 by 12.422%.

  • Which is a Better Dividend Stock GRDN or ENSG?

    Guardian Pharmacy Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Ensign Group, Inc. offers a yield of 0.12% to investors and pays a quarterly dividend of $0.07 per share. Guardian Pharmacy Services, Inc. pays 128.01% of its earnings as a dividend. The Ensign Group, Inc. pays out 4.32% of its earnings as a dividend. The Ensign Group, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Guardian Pharmacy Services, Inc.'s is not.

  • Which has Better Financial Ratios GRDN or ENSG?

    Guardian Pharmacy Services, Inc. quarterly revenues are $377.4M, which are smaller than The Ensign Group, Inc. quarterly revenues of $1.4B. Guardian Pharmacy Services, Inc.'s net income of $9.6M is lower than The Ensign Group, Inc.'s net income of $95.5M. Notably, Guardian Pharmacy Services, Inc.'s price-to-earnings ratio is 52.69x while The Ensign Group, Inc.'s PE ratio is 36.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services, Inc. is 1.53x versus 2.45x for The Ensign Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services, Inc.
    1.53x 52.69x $377.4M $9.6M
    ENSG
    The Ensign Group, Inc.
    2.45x 36.04x $1.4B $95.5M
  • Which has Higher Returns GRDN or LFST?

    Lifestance Health Group, Inc. has a net margin of 2.54% compared to Guardian Pharmacy Services, Inc.'s net margin of 0.3%. Guardian Pharmacy Services, Inc.'s return on equity of 24.04% beat Lifestance Health Group, Inc.'s return on equity of -0.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services, Inc.
    19.8% $0.15 $229.6M
    LFST
    Lifestance Health Group, Inc.
    28.32% $0.00 $2B
  • What do Analysts Say About GRDN or LFST?

    Guardian Pharmacy Services, Inc. has a consensus price target of $35.00, signalling upside risk potential of 4.35%. On the other hand Lifestance Health Group, Inc. has an analysts' consensus of $8.89 which suggests that it could grow by 24.32%. Given that Lifestance Health Group, Inc. has higher upside potential than Guardian Pharmacy Services, Inc., analysts believe Lifestance Health Group, Inc. is more attractive than Guardian Pharmacy Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services, Inc.
    3 0 0
    LFST
    Lifestance Health Group, Inc.
    7 1 0
  • Is GRDN or LFST More Risky?

    Guardian Pharmacy Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Lifestance Health Group, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock GRDN or LFST?

    Guardian Pharmacy Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lifestance Health Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services, Inc. pays 128.01% of its earnings as a dividend. Lifestance Health Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GRDN or LFST?

    Guardian Pharmacy Services, Inc. quarterly revenues are $377.4M, which are larger than Lifestance Health Group, Inc. quarterly revenues of $363.8M. Guardian Pharmacy Services, Inc.'s net income of $9.6M is higher than Lifestance Health Group, Inc.'s net income of $1.1M. Notably, Guardian Pharmacy Services, Inc.'s price-to-earnings ratio is 52.69x while Lifestance Health Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services, Inc. is 1.53x versus 2.02x for Lifestance Health Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services, Inc.
    1.53x 52.69x $377.4M $9.6M
    LFST
    Lifestance Health Group, Inc.
    2.02x -- $363.8M $1.1M
  • Which has Higher Returns GRDN or PACS?

    PACS Group, Inc. has a net margin of 2.54% compared to Guardian Pharmacy Services, Inc.'s net margin of 3.89%. Guardian Pharmacy Services, Inc.'s return on equity of 24.04% beat PACS Group, Inc.'s return on equity of 21.93%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services, Inc.
    19.8% $0.15 $229.6M
    PACS
    PACS Group, Inc.
    14.04% $0.32 $4.5B
  • What do Analysts Say About GRDN or PACS?

    Guardian Pharmacy Services, Inc. has a consensus price target of $35.00, signalling upside risk potential of 4.35%. On the other hand PACS Group, Inc. has an analysts' consensus of $44.20 which suggests that it could grow by 14.27%. Given that PACS Group, Inc. has higher upside potential than Guardian Pharmacy Services, Inc., analysts believe PACS Group, Inc. is more attractive than Guardian Pharmacy Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services, Inc.
    3 0 0
    PACS
    PACS Group, Inc.
    3 0 0
  • Is GRDN or PACS More Risky?

    Guardian Pharmacy Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison PACS Group, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock GRDN or PACS?

    Guardian Pharmacy Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PACS Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services, Inc. pays 128.01% of its earnings as a dividend. PACS Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GRDN or PACS?

    Guardian Pharmacy Services, Inc. quarterly revenues are $377.4M, which are smaller than PACS Group, Inc. quarterly revenues of $1.3B. Guardian Pharmacy Services, Inc.'s net income of $9.6M is lower than PACS Group, Inc.'s net income of $52.3M. Notably, Guardian Pharmacy Services, Inc.'s price-to-earnings ratio is 52.69x while PACS Group, Inc.'s PE ratio is 37.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services, Inc. is 1.53x versus 1.23x for PACS Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services, Inc.
    1.53x 52.69x $377.4M $9.6M
    PACS
    PACS Group, Inc.
    1.23x 37.30x $1.3B $52.3M
  • Which has Higher Returns GRDN or PNTG?

    The Pennant Group, Inc. has a net margin of 2.54% compared to Guardian Pharmacy Services, Inc.'s net margin of 3.01%. Guardian Pharmacy Services, Inc.'s return on equity of 24.04% beat The Pennant Group, Inc.'s return on equity of 9.98%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services, Inc.
    19.8% $0.15 $229.6M
    PNTG
    The Pennant Group, Inc.
    12.87% $0.17 $645.9M
  • What do Analysts Say About GRDN or PNTG?

    Guardian Pharmacy Services, Inc. has a consensus price target of $35.00, signalling upside risk potential of 4.35%. On the other hand The Pennant Group, Inc. has an analysts' consensus of $37.50 which suggests that it could grow by 16.03%. Given that The Pennant Group, Inc. has higher upside potential than Guardian Pharmacy Services, Inc., analysts believe The Pennant Group, Inc. is more attractive than Guardian Pharmacy Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services, Inc.
    3 0 0
    PNTG
    The Pennant Group, Inc.
    6 0 0
  • Is GRDN or PNTG More Risky?

    Guardian Pharmacy Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Pennant Group, Inc. has a beta of 1.273, suggesting its more volatile than the S&P 500 by 27.274%.

  • Which is a Better Dividend Stock GRDN or PNTG?

    Guardian Pharmacy Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Pennant Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services, Inc. pays 128.01% of its earnings as a dividend. The Pennant Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GRDN or PNTG?

    Guardian Pharmacy Services, Inc. quarterly revenues are $377.4M, which are larger than The Pennant Group, Inc. quarterly revenues of $229M. Guardian Pharmacy Services, Inc.'s net income of $9.6M is higher than The Pennant Group, Inc.'s net income of $6.9M. Notably, Guardian Pharmacy Services, Inc.'s price-to-earnings ratio is 52.69x while The Pennant Group, Inc.'s PE ratio is 42.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services, Inc. is 1.53x versus 1.35x for The Pennant Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services, Inc.
    1.53x 52.69x $377.4M $9.6M
    PNTG
    The Pennant Group, Inc.
    1.35x 42.72x $229M $6.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 23

RingCentral, Inc. [RNG] is down 12.48% over the past day.

Sell
9
FROG alert for Feb 23

JFrog Ltd. [FROG] is down 7.95% over the past day.

Buy
72
SNSE alert for Feb 23

Sensei Biotherapeutics, Inc. [SNSE] is down 2.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock